CXCR4 and renal cell carcinoma: Anti-CD3/CD28-Teff stimulation did not affect CXCR4 frequency (Supplementary Fig. S3a) and R54 did not affect Teff proliferation (Supplementary Fig. S3b) in both RCC- and HD-samples.